Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 4/20 | 0.38 |
| ▸ | LMNA | P02545 | 4/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | TSHR | P16473 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1357948 | 0.97 | CA1 (0.43) | CA1CA2HTTLMNASMN1; SMN2 | |
| SCHEMBL11143490 | 0.73 | LMNA (0.34) | HTTLMNASMN1; SMN2NPC1RAB9A | |
| SCHEMBL11108737 | 0.72 | — | — | |
| SCHEMBL27100041 | 0.72 | SMN1; SMN2 (0.35) | CA1CA2HTTLMNASMN1; SMN2 | |
| SCHEMBL22883321 | 0.72 | KDM4E (0.36) | CA1CA2HTTALDH1A1TSHR | |
| SCHEMBL21462096 | 0.72 | CA1 (0.54) | CA1CA2LMNANPC1RAB9A | |
| SCHEMBL21423123 | 0.70 | LMNA (0.34) | CA1HTTLMNASMN1; SMN2NPC1 | |
| SCHEMBL22883621 | 0.70 | — | — | |
| SCHEMBL7212342 | 0.70 | CA1 (0.43) | CA1CA2 | |
| SCHEMBL11872162 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230331687-A1 | Acesulfame Potassium Compositions and Processes for Producing Same | CELANESE INT CORP (US) | 2023-10-19 | — | — | US | disclosed |
| US-20230322698-A1 | Acesulfame Potassium Compositions and Processes for Producing Same | CELANESE INT CORP (US) | 2023-10-12 | — | — | US | disclosed |
| US-20230322696-A1 | Acesulfame Potassium Compositions and Processes for Producing Same | CELANESE INT CORP (US) | 2023-10-12 | — | — | US | disclosed |
| US-20230322697-A1 | Acesulfame Potassium Compositions and Processes for Producing Same | CELANESE INT CORP (US) | 2023-10-12 | — | — | US | disclosed |
| US-11731948-B2 | Acesulfame potassium compositions and processes for producing same | CELANESE INTERNATIONAL CORPORATION (US) | 2023-08-22 | — | — | US | disclosed |
| US-11724994-B2 | Acesulfame potassium compositions and processes for producing same | CELANESE INTERNATIONAL CORPORATION (US) | 2023-08-15 | — | — | US | disclosed |
| US-11724993-B2 | Acesulfame potassium compositions and processes for producing same | CELANESE INTERNATIONAL CORPORATION (US) | 2023-08-15 | — | — | US | disclosed |
| US-11718594-B2 | Acesulfame potassium compositions and processes for producing same | CELANESE INTERNATIONAL CORPORATION (US) | 2023-08-08 | — | — | US | disclosed |
| EP-3907220-A1 | ACESULFAME POTASSIUM COMPOSITIONS AND PROCESSES FOR PRODUCING SAME | Celanese International Corporation (US) | 2021-11-10 | — | — | EP | disclosed |
| US-20210221779-A1 | Acesulfame Potassium Compositions and Processes for Producing Same | CELANESE INTERNATIONAL CORPORATION | 2021-07-22 | — | — | US | disclosed |
| WO-2018057389-A1 | ACESULFAME POTASSIUM COMPOSITIONS AND PROCESSES FOR PRODUCING SAME | CELANESE INTERNATIONAL CORPORATION (US) | 2018-03-29 | — | — | WO | disclosed |
| WO-2018057386-A1 | ACESULFAME POTASSIUM COMPOSITIONS AND PROCESSES FOR PRODUCING SAME | CELANESE INTERNATIONAL CORPORATION (US) | 2018-03-29 | — | — | WO | disclosed |
| WO-2018057388-A1 | ACESULFAME POTASSIUM COMPOSITIONS AND PROCESSES FOR PRODUCING SAME | CELANESE INTERNATIONAL CORPORATION (US) | 2018-03-29 | — | — | WO | disclosed |
| WO-2018057387-A1 | ACESULFAME POTASSIUM COMPOSITIONS AND PROCESSES FOR PRODUCING SAME | CELANESE INTERNATIONAL CORPORATION (US) | 2018-03-29 | — | — | WO | disclosed |
| US-20180079734-A1 | ACESULFAME POTASSIUM COMPOSITIONS AND PROCESSES FOR PRODUCING SAME | CELANESE INTERNATIONAL CORPORATION | 2018-03-22 | — | — | US | disclosed |
| US-20180079736-A1 | ACESULFAME POTASSIUM COMPOSITIONS AND PROCESSES FOR PRODUCING SAME | CELANESE INTERNATIONAL CORPORATION | 2018-03-22 | — | — | US | disclosed |
| US-20180079735-A1 | ACESULFAME POTASSIUM COMPOSITIONS AND PROCESSES FOR PRODUCING SAME | CELANESE INTERNATIONAL CORPORATION | 2018-03-22 | — | — | US | disclosed |
| US-20180079733-A1 | ACESULFAME POTASSIUM COMPOSITIONS AND PROCESSES FOR PRODUCING SAME | CELANESE INTERNATIONAL CORPORATION | 2018-03-22 | — | — | US | disclosed |
| CN-107820490-A | Acesulfame potassium composition and process for producing the same | 国际人造丝公司 | 2018-03-20 | — | — | CN | disclosed |
| CN-107820491-A | Acesulfame potassium composition and process for producing the same | 国际人造丝公司 | 2018-03-20 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11718594-B2 | Acesulfame potassium compositions and processes for producing same | ACE, AGT, KCNJ1 | CA1 255/4885CA2 115/4885HTT 1849/4885 |
| US-20180079734-A1 | ACESULFAME POTASSIUM COMPOSITIONS AND PROCESSES FOR PRODUCING SAME | ACE, AGT, KCNJ1 | CA1 255/4885CA2 115/4885HTT 1849/4885 |
| US-11731948-B2 | Acesulfame potassium compositions and processes for producing same | AGT, ACE, HCN4 | CA1 25/4885CA2 50/4885HTT 779/4885 |
| US-20180079735-A1 | ACESULFAME POTASSIUM COMPOSITIONS AND PROCESSES FOR PRODUCING SAME | AGT, ACE, TST | CA1 57/4885CA2 42/4885HTT 1866/4885 |
| US-20230322697-A1 | Acesulfame Potassium Compositions and Processes for Producing Same | AGT, ACE, TST | CA1 57/4885CA2 42/4885HTT 1866/4885 |
| US-20230322696-A1 | Acesulfame Potassium Compositions and Processes for Producing Same | ACE, AGT, KCNJ1 | CA1 255/4885CA2 115/4885HTT 1849/4885 |
| US-20230331687-A1 | Acesulfame Potassium Compositions and Processes for Producing Same | ACE, AGT, TST | CA1 49/4885CA2 43/4885HTT 1956/4885 |
| US-20210221779-A1 | Acesulfame Potassium Compositions and Processes for Producing Same | ACE, AGT, TST | CA1 49/4885CA2 43/4885HTT 1956/4885 |
| US-11724994-B2 | Acesulfame potassium compositions and processes for producing same | AGT, ACE, TST | CA1 57/4885CA2 42/4885HTT 1866/4885 |
| US-20230322698-A1 | Acesulfame Potassium Compositions and Processes for Producing Same | AGT, ACE, HCN4 | CA1 25/4885CA2 50/4885HTT 779/4885 |
| US-20180079733-A1 | ACESULFAME POTASSIUM COMPOSITIONS AND PROCESSES FOR PRODUCING SAME | ACE, AGT, TST | CA1 49/4885CA2 43/4885HTT 1956/4885 |
| US-20180079736-A1 | ACESULFAME POTASSIUM COMPOSITIONS AND PROCESSES FOR PRODUCING SAME | AGT, ACE, HCN4 | CA1 25/4885CA2 50/4885HTT 779/4885 |
| US-11724993-B2 | Acesulfame potassium compositions and processes for producing same | ACE, AGT, TST | CA1 49/4885CA2 43/4885HTT 1956/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.